125 related articles for article (PubMed ID: 36907324)
21. HIPK2-a therapeutical target to be (re)activated for tumor suppression: role in p53 activation and HIF-1α inhibition.
Nardinocchi L; Puca R; Givol D; D'Orazi G
Cell Cycle; 2010 Apr; 9(7):1270-5. PubMed ID: 20234185
[TBL] [Abstract][Full Text] [Related]
22. High glucose-induced Smad3 linker phosphorylation and CCN2 expression are inhibited by dapagliflozin in a diabetic tubule epithelial cell model.
Pan X; Phanish MK; Baines DL; Dockrell MEC
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34003249
[TBL] [Abstract][Full Text] [Related]
23. Identification of selective homeodomain interacting protein kinase 2 inhibitors, a potential treatment for renal fibrosis.
Hu L; Wang G; Zhao C; Peng Z; Tao L; Chen Z; Hu G; Li Q
Bioorg Chem; 2022 Sep; 126():105866. PubMed ID: 35636124
[TBL] [Abstract][Full Text] [Related]
24. C-Reactive Protein Promotes Diabetic Kidney Disease in db/db Mice via the CD32b-Smad3-mTOR signaling Pathway.
You YK; Huang XR; Chen HY; Lyu XF; Liu HF; Lan HY
Sci Rep; 2016 May; 6():26740. PubMed ID: 27221338
[TBL] [Abstract][Full Text] [Related]
25. Inactivation of homeodomain-interacting protein kinase 2 promotes oral squamous cell carcinoma metastasis through inhibition of P53-dependent E-cadherin expression.
Zheng X; Pan Y; Chen X; Xia S; Hu Y; Zhou Y; Zhang J
Cancer Sci; 2021 Jan; 112(1):117-132. PubMed ID: 33063904
[TBL] [Abstract][Full Text] [Related]
26. ChREBP Deficiency Suppresses Renal Inflammation and Fibrosis Via Inhibiting NLRP3 Inflammasome Activation in Diabetic Kidney Disease.
Chen N; Yang Z; Mu L; Wu M; Song J; Zhou T; Shi Y
Discov Med; 2022; 33(169):69-83. PubMed ID: 36274225
[TBL] [Abstract][Full Text] [Related]
27. Homeodomain-interacting protein kinase 2 is the ionizing radiation-activated p53 serine 46 kinase and is regulated by ATM.
Dauth I; Krüger J; Hofmann TG
Cancer Res; 2007 Mar; 67(5):2274-9. PubMed ID: 17332358
[TBL] [Abstract][Full Text] [Related]
28. Zyxin is a critical regulator of the apoptotic HIPK2-p53 signaling axis.
Crone J; Glas C; Schultheiss K; Moehlenbrink J; Krieghoff-Henning E; Hofmann TG
Cancer Res; 2011 Mar; 71(6):2350-9. PubMed ID: 21248071
[TBL] [Abstract][Full Text] [Related]
29. DsbA-L mediated renal tubulointerstitial fibrosis in UUO mice.
Li X; Pan J; Li H; Li G; Liu X; Liu B; He Z; Peng Z; Zhang H; Li Y; Xiang X; Chai X; Yuan Y; Zheng P; Liu F; Zhang D
Nat Commun; 2020 Sep; 11(1):4467. PubMed ID: 32948751
[TBL] [Abstract][Full Text] [Related]
30. Identification and characterization of HIPK2 interacting with p73 and modulating functions of the p53 family in vivo.
Kim EJ; Park JS; Um SJ
J Biol Chem; 2002 Aug; 277(35):32020-8. PubMed ID: 11925430
[TBL] [Abstract][Full Text] [Related]
31. Novel lncRNA Erbb4-IR Promotes Diabetic Kidney Injury in
Sun SF; Tang PMK; Feng M; Xiao J; Huang XR; Li P; Ma RCW; Lan HY
Diabetes; 2018 Apr; 67(4):731-744. PubMed ID: 29222368
[TBL] [Abstract][Full Text] [Related]
32. Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53.
Sung KS; Lee YA; Kim ET; Lee SR; Ahn JH; Choi CY
Exp Cell Res; 2011 Apr; 317(7):1060-70. PubMed ID: 21192925
[TBL] [Abstract][Full Text] [Related]
33. Endothelial or vascular smooth muscle cell-specific expression of human NOX5 exacerbates renal inflammation, fibrosis and albuminuria in the Akita mouse.
Jha JC; Dai A; Holterman CE; Cooper ME; Touyz RM; Kennedy CR; Jandeleit-Dahm KAM
Diabetologia; 2019 Sep; 62(9):1712-1726. PubMed ID: 31222503
[TBL] [Abstract][Full Text] [Related]
34. Exosomal miR-19a from adipose-derived stem cells suppresses differentiation of corneal keratocytes into myofibroblasts.
Shen T; Zheng Q; Luo H; Li X; Chen Z; Song Z; Zhou G; Hong C
Aging (Albany NY); 2020 Feb; 12(5):4093-4110. PubMed ID: 32112551
[TBL] [Abstract][Full Text] [Related]
35. The Tyrosine Kinase c-Abl Promotes Homeodomain-interacting Protein Kinase 2 (HIPK2) Accumulation and Activation in Response to DNA Damage.
Reuven N; Adler J; Porat Z; Polonio-Vallon T; Hofmann TG; Shaul Y
J Biol Chem; 2015 Jul; 290(27):16478-88. PubMed ID: 25944899
[TBL] [Abstract][Full Text] [Related]
36. HIPK2 attenuates bleomycin-induced pulmonary fibrosis by suppressing the Wnt/β-catenin signaling pathway.
Wang F; Zhang Y; Ren J; Yu W
Folia Histochem Cytobiol; 2022; 60(3):247-259. PubMed ID: 36004621
[TBL] [Abstract][Full Text] [Related]
37. Hyperglycemia triggers HIPK2 protein degradation.
Baldari S; Garufi A; Granato M; Cuomo L; Pistritto G; Cirone M; D'Orazi G
Oncotarget; 2017 Jan; 8(1):1190-1203. PubMed ID: 27901482
[TBL] [Abstract][Full Text] [Related]
38. Dicer deficiency in proximal tubules exacerbates renal injury and tubulointerstitial fibrosis and upregulates Smad2/3.
Ma Z; Wei Q; Zhang M; Chen JK; Dong Z
Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1822-F1832. PubMed ID: 30280598
[TBL] [Abstract][Full Text] [Related]
39. Recent advances in the development of HIPK2 inhibitors as anti-renal fibrosis agents.
Hao C; Cao M; Ouyang H; Chen Z; Hu G; Li Q
Future Med Chem; 2023 Mar; 15(5):453-465. PubMed ID: 37013895
[TBL] [Abstract][Full Text] [Related]
40. Yishen Tongluo formula alleviates diabetic kidney disease through regulating Sirt6/TGF-β1/Smad2/3 pathway and promoting degradation of TGF-β1.
Zhang X; Zhao L; Xiang S; Sun Y; Wang P; Chen JJ; Teo BS; Xie Z; Zhang Z; Xu J
J Ethnopharmacol; 2023 May; 307():116243. PubMed ID: 36791927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
